research
Defining The Dose Of Gemtuzumab Ozogamicin In Combination With Induction Chemotherapy In Acute Myeloid Leukemia: A Comparison Of 3 Mg/M2 With 6 Mg/M2 In The NCRI AML17 Trial
- Publication date
- 26 February 2016
- Publisher
- 'Ferrata Storti Foundation (Haematologica)'